Research library / Creatine

DD Mostly mechanistic or early data. Shown openly. How we grade →Single-arm pilot · 20 patients

Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition

A Smith, I Choi, P Lee, D Sullivan, J Burns, R Swerdlow et al. Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2025.

Published Sources checked 1 sourceEverstack research teamHow we work

In plain language
20 g a day for 8 weeks was feasible in Alzheimer's disease, raised brain creatine by 11% and was followed by better scores on some tests; 13 mild side effects.
Limits
No placebo group, so it cannot show efficacy; creatine donated by Life Extension.
Which of our grades it feeds
Source
doi.org/10.1002/trc2.70101 · PubMed 40395689 · Free full text

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.